Advice
in the absence of a submission from the holder of the marketing authorisation:
glucosamine sulphate (Dolenio®) is not recommended for use within NHS Scotland.
Indication under review: symptomatic treatment of mild to moderate osteoarthritis (OA) of the knee.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice38KB (PDF)
Medicine details
- Medicine name:
- glucosamine sulphate (Dolenio®)
- SMC ID:
- 729/11
- Indication:
- Symptomatic treatment of mild to moderate osteoarthritis (OA) of the knee
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 August 2011